US Stock MarketDetailed Quotes

Acurx Pharmaceuticals (ACXP)

Watchlist
  • 1.530
  • +0.030+2.00%
Close Mar 2 15:59 ET
3.90MMarket Cap-0.19P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acurx Pharmaceuticals (ACXP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.10%-1.88M
42.00%-1.67M
33.02%-2.05M
-5.94%-10.38M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
Net income from continuing operations
29.37%-1.99M
45.50%-2.25M
50.91%-2.15M
3.26%-14.1M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
Change In working capital
-238.04%-228.03K
1,396.14%165.31K
-401.30%-345.98K
-71.89%284.09K
97.75%-6.98K
-12.22%165.19K
-98.96%11.05K
62.53%114.83K
-19.02%1.01M
-132.56%-310.15K
-Change in receivables
--0
21.36%-40.21K
-60.42%51.13K
160.42%78.03K
135.81%46.25K
---46.25K
---51.13K
--129.16K
---129.16K
---129.16K
-Change in prepaid assets
-329.63%-104.68K
454.08%108.05K
25.18%-61.45K
-96.45%5.65K
42,135.19%22.7K
388.88%45.59K
-83.28%19.5K
-240.75%-82.13K
424.50%159.18K
-100.07%-54
-Change in payables and accrued expense
-174.38%-123.35K
128.39%97.47K
-595.04%-335.66K
-79.57%200.4K
58.04%-75.92K
-18.69%165.85K
-95.49%42.68K
451.39%67.8K
-19.46%980.75K
-120.57%-180.94K
Cash from discontinued investing activities
Operating cash flow
14.10%-1.88M
42.00%-1.67M
33.02%-2.05M
-5.94%-10.38M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
8.30%1.72M
865.24%3.09M
-33.73%2.99M
-18.96%6.62M
-95.79%194.55K
1.59M
-90.96%320.21K
4.51M
120.92%8.16M
461,963,800.00%4.62M
Net common stock issuance
8.30%1.72M
90.58%610.26K
-30.49%2.99M
7.76%6.41M
-91.90%194.55K
--1.59M
-90.96%320.21K
--4.3M
60.86%5.94M
240,063,900.00%2.4M
Proceeds from stock option exercised by employees
--0
--2.48M
--0
-90.53%210.2K
--0
--0
--0
--210.2K
17,069,684.62%2.22M
--2.22M
Cash from discontinued financing activities
Financing cash flow
8.30%1.72M
865.24%3.09M
-33.73%2.99M
-18.96%6.62M
-95.79%194.55K
--1.59M
-90.96%320.21K
--4.51M
120.92%8.16M
461,963,800.00%4.62M
Net cash flow
Beginning cash position
-4.66%6.06M
-47.94%4.64M
-50.41%3.71M
-17.97%7.47M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-29.69%9.11M
-33.51%7.05M
Current changes in cash
73.70%-157.33K
155.48%1.42M
-35.22%937.17K
-130.07%-3.77M
-587.33%-2.06M
71.42%-598.29K
-230.15%-2.56M
174.85%1.45M
57.43%-1.64M
128.21%421.86K
End cash Position
2.50%5.91M
-4.66%6.06M
-47.94%4.64M
-50.41%3.71M
-50.41%3.71M
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
Free cash flow
14.10%-1.88M
42.00%-1.67M
33.02%-2.05M
-5.94%-10.38M
46.39%-2.25M
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.10%-1.88M42.00%-1.67M33.02%-2.05M-5.94%-10.38M46.39%-2.25M-4.60%-2.19M-82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M
Net income from continuing operations 29.37%-1.99M45.50%-2.25M50.91%-2.15M3.26%-14.1M45.61%-2.78M9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M
Change In working capital -238.04%-228.03K1,396.14%165.31K-401.30%-345.98K-71.89%284.09K97.75%-6.98K-12.22%165.19K-98.96%11.05K62.53%114.83K-19.02%1.01M-132.56%-310.15K
-Change in receivables --021.36%-40.21K-60.42%51.13K160.42%78.03K135.81%46.25K---46.25K---51.13K--129.16K---129.16K---129.16K
-Change in prepaid assets -329.63%-104.68K454.08%108.05K25.18%-61.45K-96.45%5.65K42,135.19%22.7K388.88%45.59K-83.28%19.5K-240.75%-82.13K424.50%159.18K-100.07%-54
-Change in payables and accrued expense -174.38%-123.35K128.39%97.47K-595.04%-335.66K-79.57%200.4K58.04%-75.92K-18.69%165.85K-95.49%42.68K451.39%67.8K-19.46%980.75K-120.57%-180.94K
Cash from discontinued investing activities
Operating cash flow 14.10%-1.88M42.00%-1.67M33.02%-2.05M-5.94%-10.38M46.39%-2.25M-4.60%-2.19M-82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 8.30%1.72M865.24%3.09M-33.73%2.99M-18.96%6.62M-95.79%194.55K1.59M-90.96%320.21K4.51M120.92%8.16M461,963,800.00%4.62M
Net common stock issuance 8.30%1.72M90.58%610.26K-30.49%2.99M7.76%6.41M-91.90%194.55K--1.59M-90.96%320.21K--4.3M60.86%5.94M240,063,900.00%2.4M
Proceeds from stock option exercised by employees --0--2.48M--0-90.53%210.2K--0--0--0--210.2K17,069,684.62%2.22M--2.22M
Cash from discontinued financing activities
Financing cash flow 8.30%1.72M865.24%3.09M-33.73%2.99M-18.96%6.62M-95.79%194.55K--1.59M-90.96%320.21K--4.51M120.92%8.16M461,963,800.00%4.62M
Net cash flow
Beginning cash position -4.66%6.06M-47.94%4.64M-50.41%3.71M-17.97%7.47M-18.29%5.76M-30.45%6.36M24.27%8.92M-17.97%7.47M-29.69%9.11M-33.51%7.05M
Current changes in cash 73.70%-157.33K155.48%1.42M-35.22%937.17K-130.07%-3.77M-587.33%-2.06M71.42%-598.29K-230.15%-2.56M174.85%1.45M57.43%-1.64M128.21%421.86K
End cash Position 2.50%5.91M-4.66%6.06M-47.94%4.64M-50.41%3.71M-50.41%3.71M-18.29%5.76M-30.45%6.36M24.27%8.92M-17.97%7.47M-17.97%7.47M
Free cash flow 14.10%-1.88M42.00%-1.67M33.02%-2.05M-5.94%-10.38M46.39%-2.25M-4.60%-2.19M-82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.46%
Sample Name
Sample Code
 +2.99%
Sample Name
Sample Code
 +1.48%
4
Clean Energy Fuels
CLNE
+1.33%
5
Block
XYZ
+1.18%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +7.81%
Sample Name
Sample Code
 +5.70%
Sample Name
Sample Code
 +3.40%
4
ASE Technology
ASX
+3.07%
5
Futu Holdings Ltd
FUTU
+1.96%
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More
Is the US stock market entering a recovery phase? Trump and Jensen Huang both 'chiming in' with these three key trends worth watching!
Wait for the right moment to act

- No more -